Article content material
- CDX Prostate is a blood-based diagnostic instrument that makes use of AI-powered studying to find out the chance of aggressive prostate most cancers.
- Florida-based Protean BioDiagnostics will now provide the validated CDX Prostate danger rating to healthcare suppliers and their sufferers suspected of getting aggressive prostate most cancers.
EDMONTON, Alberta — Nanostics Inc., a precision well being firm creating diagnostic checks with its ClarityDX® platform expertise, and Protean BioDiagnostics Inc. (Protean) in the present day introduced their partnership to supply CDX Prostate in the US.
Article content material
CDX Prostate makes use of organic information, medical info, and AI-powered studying fashions to generate a danger rating for aggressive prostate most cancers, marking a big development in prostate most cancers screening. It gives crucial help to males and their healthcare suppliers in making extra knowledgeable selections about whether or not to proceed with a biopsy following a excessive prostate-specific antigen (PSA) take a look at end result or an irregular Digital Rectal Examination (DRE).
“This settlement with Protean is a big milestone for Nanostics – we will now present CDX Prostate to males within the US,” stated Dr. John Lewis, CEO of Nanostics and Chicken Canine Chair of Translational Oncology on the College of Alberta. “When used as a reflex take a look at, CDX Prostate is a robust instrument to assist establish males with aggressive prostate most cancers sooner, main to higher outcomes whereas additionally minimizing the destructive results related to overdiagnosis of the illness.”
“At Protean, we’re devoted to offering entry to the best-in-class precision drugs options,” stated Dr. Anthony Magliocco, CEO of Protean BioDiagnostics. “We’re excited to have the ability to present CDX Prostate as a part of our most cancers screening program”.
Protean’s testing service is carried out in its CLIA-certified laboratory in Orlando, Florida. For extra details about CDX Prostate or to order the take a look at go to https://www.proteanbiodx.com/cdxprostate#pcdx-order. In Canada, the take a look at is on the market in most provinces by Nanostics’ CPSA-accredited lab in Edmonton, Alberta. Go to www.nanosticsdx.com for extra info or to order the take a look at. In Quebec, testing providers can be found from CDL Laboratories, go to cdllaboratories.com for extra info.
About Protean BioDiagnostics Inc.
Protean BioDiagnostics Inc. is bringing precision care diagnostics to all sufferers, all over the place, by its progressive Protean MAPS™ System with built-in Digital Tumor Boards. As well as, Protean assists world-class pharmaceutical and biotech firms in creating medical assays and companion diagnostics from its CLIA-certified, CAP-accredited laboratory in Orlando, FL. To be taught extra go to www.proteanbiodx.com. Questions on CDX Prostate? Name us at: 1 (754) 242 9682 or e-mail us at: information@proteanbiodx.com. Observe Protean on LinkedIn, Twitter or YouTube.
About Nanostics Inc.
Nanostics Inc is a non-public Canadian firm that develops and commercializes novel and noninvasive diagnostic checks. Its core expertise, ClarityDX®, makes use of superior machine studying algorithms to create a illness danger rating that predicts the presence of illnesses. ClarityDX is relevant to a variety of cancers and different illnesses. Nanostics’ lead product, CDX Prostate, additionally known as ClarityDX Prostate® in Canada, is a take a look at that improves the accuracy of detecting clinically vital prostate most cancers. Learn extra at: www.nanosticsdx.com. Observe Nanostics on LinkedIn, YouTube, Fb, and Instagram.
View supply model on businesswire.com: https://www.businesswire.com/information/residence/20240924980626/en/
Contacts
Nanostics
For company inquiries:
John Lewis, Ph.D.
CEO, Nanostics, Inc.
information@nanosticsdx.com
For media inquiries:
Perrin Beatty, Ph.D.
Communications
+1-800-672-2027
Protean BioDiagnostics Contacts
For company inquiries:
Anthony Magliocco, MD
President and CEO of Protean BioDiagnostics
magliocco@proteanbiodx.com
+1 (813) 817-2042
For media inquiries:
Rocky Haag
Director of Exterior Affairs
rocky.haag@proteanbiodx.com
+1 (407) 583-9443
#distro
Share this text in your social community
